RATAN SILK MILLS

Novo Nordisk slashes Ozempic, Wegovy prices as generic competition heats up

Following the loss of patent protection, Novo Nordisk will reduce prices for Ozempic and Wegovy by up to 48%, starting April 1. The company aims…

The ‘fog of war’ could soon lift for stocks. These risks still loom.

The worst quarter in four years won’t be undone by White House messaging alone.

Gold rate rises 1%, silver jumps 4% on MCX; should investors buy now?

As gold prices rise by 1% and silver by 4% on the MCX, experts suggest a cautious approach to buying. With geopolitical tensions and central…

Quote of the day by Seth Klarman: "Most investors are primarily oriented toward return, how much they can make, and pay little attention to risk, how much they can lose."

Seth Klarman’s philosophy highlights a crucial investing truth: most investors chase returns while neglecting risk. This return-first mindset leads to costly mistakes, as true wealth…

US Stock Market Today | Dow Jones | Nasdaq Live: US stock futures gain on Mideast de-escalation hopes

Silver rate in India down 45% from record high: Right time to buy the white metal now?

Silver rates in India have dropped 45% from record highs due to a stronger dollar and rising inflation risks from crude oil prices. The dollar…

US stock market today: Dow Jones, S&P 500 futures signal strong start for Wall Street on US-Iran war de-escalation hopes

US stock markets are poised for a positive opening amid de-escalation hopes in the Middle East, although major indices face their worst monthly decline since…

FY26 multibaggers: 10 stocks jump 125% to 1,655% in one year

In FY26, a select group of Indian stocks delivered exceptional returns. Twenty companies with market caps above Rs 3,000 crore and significant trading volume saw…

Starting a consumer brand is easier than ever in India. Scaling it is getting harder

Startups are launching faster and finding early traction, but distribution gaps, rising expectations and shifting consumer behaviour are making it harder to sustain growth.

Blackstone hires bankers for $500 million AGS Health IPO, eyes 3x valuation jump in a year

The potential offer comes amid a cooling IPO market, in which big offers have failed to generate listing gains for selling shareholders since January.

Zerodha's Nithin Kamath says AI offers an edge, but can't generate alpha in markets

Zerodha founder and CEO Nithin Kamath believes AI is an edge, which can make investors more disciplined, but not smarter.